BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 28034999)

  • 1. Perceptions of Snus Among US Adult Smokers Given Free Product.
    Meier E; Burris JL; Wahlquist A; Garrett-Mayer E; Gray KM; Alberg AJ; Cummings KM; Carpenter MJ
    Nicotine Tob Res; 2017 Dec; 20(1):22-29. PubMed ID: 28034999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized Trial to Compare Smoking Cessation Rates of Snus, With and Without Smokeless Tobacco Health-Related Information, and a Nicotine Lozenge.
    Nelson PR; Chen P; Battista DR; Pillitteri JL; Shiffman S
    Nicotine Tob Res; 2019 Jan; 21(1):88-94. PubMed ID: 29373698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A longitudinal, naturalistic study of U.S. smokers' trial and adoption of snus.
    Burris JL; Wahlquist AE; Alberg AJ; Cummings KM; Gray KM; Garrett-Mayer E; Carpenter MJ
    Addict Behav; 2016 Dec; 63():82-8. PubMed ID: 27450153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Randomized Clinical Trial of Snus Examining the Effect of Complete Versus Partial Cigarette Substitution on Smoking-Related Behaviors, and Biomarkers of Exposure.
    Meier E; Lindgren BR; Anderson A; Reisinger SA; Norton KJ; Jensen J; Strayer L; Dick L; Tang MK; Chen M; Carmella SG; Hecht SS; Murphy SE; Yang J; Stepanov I; O'Connor RJ; Shields PG; Hatsukami DK
    Nicotine Tob Res; 2020 Apr; 22(4):473-481. PubMed ID: 31321423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do never smokers make up an increasing share of snus users as cigarette smoking declines? Changes in smoking status among male snus users in Norway 2003-15.
    Lund KE; Vedøy TF; Bauld L
    Addiction; 2017 Feb; 112(2):340-348. PubMed ID: 27741374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations of Proposed Relative-Risk Warning Labels for Snus With Perceptions and Behavioral Intentions Among Tobacco Users and Nonusers.
    Rodu B; Plurphanswat N; Hughes JR; Fagerström K
    Nicotine Tob Res; 2016 May; 18(5):809-16. PubMed ID: 26253616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrasting smokers' and snus users' perceptions of personal tobacco behavior in norway.
    Lund M; Lund KE; Halkjelsvik T
    Nicotine Tob Res; 2014 Dec; 16(12):1577-85. PubMed ID: 24991039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of dual use of snus and cigarettes in a mature snus market.
    Lund KE; McNeill A
    Nicotine Tob Res; 2013 Mar; 15(3):678-84. PubMed ID: 22990221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Snus undermines quit attempts but not abstinence: a randomised clinical trial among US smokers.
    Carpenter MJ; Wahlquist AE; Burris JL; Gray KM; Garrett-Mayer E; Cummings KM; Alberg AJ
    Tob Control; 2017 Mar; 26(2):202-209. PubMed ID: 27071730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative Risk Perceptions between Snus and Cigarettes in a Snus-Prevalent Society-An Observational Study over a 16 Year Period.
    Lund KE; Vedoy TF
    Int J Environ Res Public Health; 2019 Mar; 16(5):. PubMed ID: 30862006
    [No Abstract]   [Full Text] [Related]  

  • 11. Dual use of cigarettes and Swedish snuff (snus) among young adults in Northern Finland.
    Hamari AK; Toljamo TI; Kinnula VL; Nieminen PA
    Eur J Public Health; 2013 Oct; 23(5):768-71. PubMed ID: 23002233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perceptions of relative risk of disease and addiction from cigarettes and snus.
    Lund I; Scheffels J
    Psychol Addict Behav; 2014 Jun; 28(2):367-75. PubMed ID: 23647153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is snus the same as dip? Smokers' perceptions of new smokeless tobacco advertising.
    Bahreinifar S; Sheon NM; Ling PM
    Tob Control; 2013 Mar; 22(2):84-90. PubMed ID: 21972063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interviews with smokers about smokeless tobacco products, risk messages and news articles.
    Wackowski OA; Lewis MJ; Delnevo CD
    Tob Control; 2016 Nov; 25(6):671-678. PubMed ID: 26576840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smokers' Exposure to Perceived Modified Risk Claims for E-Cigarettes, Snus, and Smokeless Tobacco in the United States.
    Wackowski OA; O'Connor RJ; Pearson JL
    Nicotine Tob Res; 2021 Feb; 23(3):605-608. PubMed ID: 32812028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How do Smokers in a Snus-Prevalent Society Consider E-cigarettes, Snus, and Nicotine Replacement Therapy Products as Relevant Replacements for Cigarettes in the Event They Should Stop Smoking?
    Vedøy TF; Lund KE
    Nicotine Tob Res; 2023 Sep; 25(11):1753-1761. PubMed ID: 37410922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral tobacco products: preference and effects among smokers.
    Hatsukami DK; Jensen J; Anderson A; Broadbent B; Allen S; Zhang Y; Severson H
    Drug Alcohol Depend; 2011 Nov; 118(2-3):230-6. PubMed ID: 21515003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alarming development of dual snus and cigarette usage among young Finnish males.
    Danielsson M; Lammi A; Siitonen S; Ollgren J; Pylkkänen L; Vasankari T
    BMC Public Health; 2019 Sep; 19(1):1249. PubMed ID: 31510968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use and perception of electronic cigarettes and snus among the U.S. population.
    Zhu SH; Gamst A; Lee M; Cummins S; Yin L; Zoref L
    PLoS One; 2013; 8(10):e79332. PubMed ID: 24250756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testing messages to reduce smokers' openness to using novel smokeless tobacco products.
    Popova L; Neilands TB; Ling PM
    Tob Control; 2014 Jul; 23(4):313-21. PubMed ID: 23467655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.